The Amikacin Sulfate Injection, cataloged under National Stock Number 6505-01-033-0058, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc. Government technical data includes 6 specifications, cited from the U.S. Government catalog. The record lists 3 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-033-0058 |
| Primary Part Number | NDC25021-0173-02 |
| Item Name | Amikacin Sulfate Injection |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR AND INTRAVENOUS |
| Primary Container Content Quantity | 2.000 MILLILITERS |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Active Medicament Medicinal Strength | EQUIVALENT TO 500 MILLIGRAMS AMIKACIN ACTIVE INGREDIENT |
| Total Primary Container Quantity | 10 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC25021-0173-02 PRIMARY | Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc (USA) |
| NDC63323-0815-02 PRIMARY | Fresenius Kabi, Llc (USA) |
| 381502 PRIMARY | Fresenius Kabi, Llc (USA) |
NSN 6505-01-033-0058 is a Amikacin Sulfate Injection, manufactured by Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-033-0058 has 3 manufacturer part numbers on file: NDC25021-0173-02 (Sagent Pharmaceuticals, Inc Dba Sagent Pharmaceuticals, Inc), NDC63323-0815-02 (Fresenius Kabi, Llc), 381502 (Fresenius Kabi, Llc).
Key specifications for NDC25021-0173-02: Administration: INTRAMUSCULAR AND INTRAVENOUS; Primary Container Content Quantity: 2.000 MILLILITERS; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 6 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.